Cost-effectiveness analysis based on the number-needed-to-treat: common sense or non-sense?

作者: Ivar Sønbø Kristiansen , Dorte Gyrd-Hansen

DOI: 10.1002/HEC.797

关键词:

摘要: This paper explores and critically discusses some of the methodological limitations using number-needed-to-treat (NNT) in economic evaluation. We argue that NNT may be a straightforward measure benefit when effect an intervention is immediate, but serious problems arise delay rather than avoidance adverse event. In this case, not robust or accurate effect, will vary considerably inconsistently over time. weakness naturally spill onto any CEA based on NNT. A literature review demonstrated CEAs were all published within last five years, studies suffered from important limitations. major imposed restrictions outcome measure, which can only strictly uni-dimensional non-generic. Using evaluations obtained at cost terms both shortcomings, reduced ability for such to serve as useful tool decision making processes. The use might better avoided. To every complicated question, there simple, straightforward, easy--and probably wrong answer (Occam's Sledgehammer).

参考文章(3)
J. L. Hutton, Number needed to treat: properties and problems Journal of The Royal Statistical Society Series A-statistics in Society. ,vol. 163, pp. 381- 402 ,(2000) , 10.1111/1467-985X.00175
Maria Grazia Franzosi, Massimo Brunetti, Roberto Marchioli, Rosa Maria Marfisi, Gianni Tognoni, Franco Valagussa, Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial. PharmacoEconomics. ,vol. 19, pp. 411- 420 ,(2001) , 10.2165/00019053-200119040-00008
David Meltzer, Accounting for future costs in medical cost-effectiveness analysis. Journal of Health Economics. ,vol. 16, pp. 33- 64 ,(1997) , 10.1016/S0167-6296(96)00507-3